Novo Nordisk India – Gurgaon Corporate Office

Novo Nordisk India Private Limited operates its Indian corporate headquarters from Gurgaon (Gurugram), Haryana. As the India subsidiary of the global Danish pharmaceutical giant, Novo Nordisk India focuses on serious chronic diseases including diabetes, obesity, haemophilia, and growth disorders. The company is a market leader in insulin and diabetes care products in India.

Products & Therapeutic Areas

Novo Nordisk India’s portfolio includes modern insulins (Tresiba, Victoza, Ryzodeg, NovoRapid, Insulatard, Mixtard), GLP-1 receptor agonists, human growth hormone (Norditropin), and coagulation factor products for haemophilia. The company invests significantly in patient education and diabetes awareness programmes across India.

Research & Market Leadership

Novo Nordisk holds a leading position in insulin sales in India and is committed to making insulin accessible through various affordability and access programmes. The Gurgaon office drives commercial strategy, regulatory affairs, medical affairs, and market access for the Indian market.

Contact Information

Company: Novo Nordisk India Pvt. Ltd.
Location: Gurgaon (Gurugram), Haryana
Business Type: Global Pharmaceutical Subsidiary – Diabetes & Chronic Disease